Active	Status	Sponsor type	Region	Phase	Filter
6 Active 9 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
He, Jie
ADAURA2, NCT05120349 / 2021-004135-89: A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection	Active, not recruiting	3	385	Europe, Canada, Japan, US, RoW	Osimertinib, AZD9291; TAGRISSO, Placebo	AstraZeneca, AstraZenecaAB	Non-Small Cell Lung Cancer	08/27	11/32
Zhang, Xiangru
No trials found
Liu, Xinling
No trials found